4045-301
ClinicalTrials.gov NCT02500381
Research payments
$9,872,390
Through program year 2021, $9,872,390 in research payments was reported against 4045-301, across 453 payments, paid by Sarepta Therapeutics, Inc..
- Paid by
- Sarepta Therapeutics, Inc.
- ClinicalTrials.gov
- NCT02500381
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $666,719 | 58 |
| 2020 | Research | $2,813,530 | 159 |
| 2019 | Research | $6,392,142 | 236 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Craig Zaidman Saint Louis, MO Named on 30 payments
- Jerry Mendell Columbus, OH Named on 29 payments
- Hoda Abdel-Hamid Pittsburgh, PA Named on 21 payments
- Barry Byrne Orlando, FL Named on 19 payments
- Nancy Kuntz Rochester, MN Named on 14 payments
- Susan Iannaccone Dallas, TX Named on 14 payments
- James Renfroe Gulf Breeze, FL Named on 13 payments
- Chet Villa Cincinnati, OH Named on 13 payments
- Richard Haas San Diego, CA Named on 13 payments
- Russell Butterfield Salt Lake City, UT Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.